$2.39T
Total marketcap
$74.81B
Total volume
BTC 50.59%     ETH 15.02%
Dominance

Lobe Sciences LOBEF Stock

0.01 USD {{ price }} -11.678833% {{change_pct}}%
Exchange
Other OTC
Market Cap
1.16M USD
LOW - HIGH [24H]
0.01 - 0.01 USD
VOLUME [24H]
1.39K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.02 USD

Lobe Sciences Price Chart

Lobe Sciences LOBEF Financial and Trading Overview

Lobe Sciences stock price 0.01 USD
Previous Close 0.02 USD
Open 0.02 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.02 - 0.02 USD
52 Week Range 0.02 - 0.27 USD
Volume 16.03K USD
Avg. Volume 62.11K USD
Market Cap 3.33M USD
Beta (5Y Monthly) 2.48337
PE Ratio (TTM) N/A
EPS (TTM) -0.02 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

LOBEF Valuation Measures

Enterprise Value 3.62M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Lobe Sciences Stock Price History

Beta (5Y Monthly) 2.48337
52-Week Change -46.37%
S&P500 52-Week Change 20.43%
52 Week High 0.27 USD
52 Week Low 0.02 USD
50-Day Moving Average 0.02 USD
200-Day Moving Average 0.04 USD

LOBEF Share Statistics

Avg. Volume (3 month) 62.11K USD
Avg. Daily Volume (10-Days) 18.04K USD
Shares Outstanding 155.14M
Float 149.8M
Short Ratio N/A
% Held by Insiders 2.53%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends August 31, 2022
Most Recent Quarter (mrq) February 28, 2023
Next Fiscal Year End August 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -95.67%
Return on Equity (ttm) -485.41%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -7585110 USD
Diluted EPS (ttm) -0.11
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 268.2K USD
Total Cash Per Share (mrq) 0.002 USD
Total Debt (mrq) 211.86K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.245
Book Value Per Share (mrq) -0.011

Cash Flow Statement

Operating Cash Flow (ttm) -2896727 USD
Levered Free Cash Flow (ttm) -566892 USD

Profile of Lobe Sciences

Country United States
State BC
City Vancouver
Address 1400 - 1199 West Hasting Street
ZIP V6E 3T5
Phone N/A
Website https://www.lobesciences.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines to enhance brain and mental health and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

Q&A For Lobe Sciences Stock

What is a current LOBEF stock price?

Lobe Sciences LOBEF stock price today per share is 0.01 USD.

How to purchase Lobe Sciences stock?

You can buy LOBEF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Lobe Sciences?

The stock symbol or ticker of Lobe Sciences is LOBEF.

Which industry does the Lobe Sciences company belong to?

The Lobe Sciences industry is Drug Manufacturers-Specialty & Generic.

How many shares does Lobe Sciences have in circulation?

The max supply of Lobe Sciences shares is 95.56M.

What is Lobe Sciences Price to Earnings Ratio (PE Ratio)?

Lobe Sciences PE Ratio is now.

What was Lobe Sciences earnings per share over the trailing 12 months (TTM)?

Lobe Sciences EPS is -0.02 USD over the trailing 12 months.

Which sector does the Lobe Sciences company belong to?

The Lobe Sciences sector is Healthcare.